Glandular Cell Neoplasm

Observed

← altered in cohorts of

HNF4A

150 / 171 cases (88 %) · ssm · TCGA-READ

—

Observed

← altered in cohorts of

PCK1

150 / 171 cases (88 %) · ssm · TCGA-READ

—

Observed

← altered in cohorts of

RIMS4

150 / 171 cases (88 %) · ssm · TCGA-READ

—

Observed

← altered in cohorts of

SGK2

150 / 171 cases (88 %) · ssm · TCGA-READ

—

Observed

← altered in cohorts of

TRPC4AP

150 / 171 cases (88 %) · ssm · TCGA-READ

—

Observed

← altered in cohorts of

BLCAP

149 / 171 cases (87 %) · ssm · TCGA-READ

—

Observed

← altered in cohorts of

BMP7

149 / 171 cases (87 %) · ssm · TCGA-READ

—

Observed

← altered in cohorts of

BPI

149 / 171 cases (87 %) · ssm · TCGA-READ

—

Observed

← altered in cohorts of

BPIFB3

149 / 171 cases (87 %) · ssm · TCGA-READ

—

Observed

← altered in cohorts of

COX4I2

149 / 171 cases (87 %) · ssm · TCGA-READ

—

Observed

← altered in cohorts of

EDN3

149 / 171 cases (87 %) · ssm · TCGA-READ

—

Observed

← altered in cohorts of

EMILIN3

149 / 171 cases (87 %) · ssm · TCGA-READ

—

Observed

← altered in cohorts of

FAM83D

149 / 171 cases (87 %) · ssm · TCGA-READ

—

Observed

← altered in cohorts of

FOXS1

149 / 171 cases (87 %) · ssm · TCGA-READ

—

Observed

Glandular Cell Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 295show all (up to 200)
→ investigated in trials for	Bevacizumabmonoclonal antibody 220 trials (93 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	220	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenibsmall molecule 183 trials (13 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	183	Observed	clinicaltrials	graph →
→ investigated in trials for	Gemcitabinesmall molecule 167 trials (45 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	167	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal antibody 154 trials (65 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	154	Observed	clinicaltrials	graph →
→ investigated in trials for	Nivolumabmonoclonal antibody 148 trials (65 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	148	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenvatinibsmall molecule 145 trials (63 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	145	Observed	clinicaltrials	graph →
→ investigated in trials for	Paclitaxelsmall molecule 139 trials (51 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	139	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumabmonoclonal antibody 130 trials (41 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	130	Observed	clinicaltrials	graph →
→ investigated in trials for	Fluorouracilsmall molecule 127 trials (30 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	127	Observed	clinicaltrials	graph →
→ investigated in trials for	Oxaliplatinsmall molecule 117 trials (30 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	117	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 104 trials (44 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	104	Observed	clinicaltrials	graph →
→ investigated in trials for	Capecitabinesmall molecule 96 trials (32 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	96	Observed	clinicaltrials	graph →
→ investigated in trials for	Nab-paclitaxel 90 trials (31 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	90	Observed	clinicaltrials	graph →
→ investigated in trials for	Atezolizumabmonoclonal antibody 86 trials (57 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	86	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall molecule 84 trials (31 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	84	Observed	clinicaltrials	graph →
→ investigated in trials for	Leucovorinsmall molecule 84 trials (22 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	84	Observed	clinicaltrials	graph →
→ investigated in trials for	Durvalumabmonoclonal antibody 82 trials (50 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	82	Observed	clinicaltrials	graph →
→ investigated in trials for	Docetaxelsmall molecule 76 trials (27 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	76	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabozantinibsmall molecule 70 trials (38 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	70	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall molecule 67 trials (19 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	67	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipilimumabmonoclonal antibody 65 trials (38 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	65	Observed	clinicaltrials	graph →
→ investigated in trials for	Irinotecansmall molecule 65 trials (19 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	65	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall molecule 60 trials (20 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	60	Observed	clinicaltrials	graph →
→ investigated in trials for	Pertuzumabmonoclonal antibody 58 trials (28 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	58	Observed	clinicaltrials	graph →
→ investigated in trials for	Sintilimabmonoclonal antibody 58 trials (28 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	58	Observed	clinicaltrials	graph →
→ investigated in trials for	Tremelimumabmonoclonal antibody 42 trials (27 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	42	Observed	clinicaltrials	graph →
→ investigated in trials for	Tislelizumabmonoclonal antibody 40 trials (18 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	40	Observed	clinicaltrials	graph →
→ investigated in trials for	Prednisonesmall molecule 36 trials (14 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	36	Observed	clinicaltrials	graph →
→ investigated in trials for	Regorafenibsmall molecule 36 trials (10 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	36	Observed	clinicaltrials	graph →
→ investigated in trials for	Camrelizumabmonoclonal antibody 35 trials (15 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	35	Observed	clinicaltrials	graph →
→ investigated in trials for	Olaparibsmall molecule 35 trials (21 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	35	Observed	clinicaltrials	graph →
→ investigated in trials for	Sunitinibsmall molecule 33 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	33	Observed	clinicaltrials	graph →
→ investigated in trials for	Toripalimabmonoclonal antibody 32 trials (12 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	32	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall molecule 31 trials (14 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	31	Observed	clinicaltrials	graph →
→ investigated in trials for	Leuprolideother 31 trials (14 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	31	Observed	clinicaltrials	graph →
→ investigated in trials for	Axitinibsmall molecule 30 trials (13 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	30	Observed	clinicaltrials	graph →
→ investigated in trials for	Enzalutamidesmall molecule 30 trials (10 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	30	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumab Emtansineadc 30 trials (13 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	30	Observed	clinicaltrials	graph →
→ investigated in trials for	Goserelinother 29 trials (15 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	29	Observed	clinicaltrials	graph →
→ investigated in trials for	Everolimussmall molecule 27 trials (5 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	27	Observed	clinicaltrials	graph →
→ investigated in trials for	Letrozolesmall molecule 27 trials (15 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	27	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenib Tosylatesmall molecule 27 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	27	Observed	clinicaltrials	graph →
→ investigated in trials for	Cetuximabmonoclonal antibody 26 trials (7 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	26	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinib Hydrochloridesmall molecule 26 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	26	Observed	clinicaltrials	graph →
→ investigated in trials for	Pyrotinibsmall molecule 24 trials (15 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	24	Observed	clinicaltrials	graph →
→ investigated in trials for	Bicalutamidesmall molecule 23 trials (7 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	23	Observed	clinicaltrials	graph →
→ investigated in trials for	Chemotherapy 23 trials (9 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	23	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinibsmall molecule 23 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	23	Observed	clinicaltrials	graph →
→ investigated in trials for	Abiraterone Acetatesmall molecule 21 trials (11 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Metforminsmall molecule 21 trials (4 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Pemetrexedsmall molecule 21 trials (4 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Tucatinibsmall molecule 21 trials (10 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Epirubicinsmall molecule 20 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	20	Observed	clinicaltrials	graph →
→ investigated in trials for	Abemaciclibsmall molecule 19 trials (11 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	19	Observed	clinicaltrials	graph →
→ investigated in trials for	Palbociclibsmall molecule 19 trials (6 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	19	Observed	clinicaltrials	graph →
→ investigated in trials for	Fulvestrantsmall molecule 18 trials (8 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	18	Observed	clinicaltrials	graph →
→ investigated in trials for	Apalutamidesmall molecule 17 trials (11 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Tamoxifensmall molecule 17 trials (8 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Neratinibsmall molecule 16 trials (9 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Aldesleukinother 15 trials (5 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	15	Observed	clinicaltrials	graph →
→ investigated in trials for	Cediranibsmall molecule 15 trials (9 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	15	Observed	clinicaltrials	graph →
→ investigated in trials for	Lapatinibsmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	15	Observed	clinicaltrials	graph →
→ investigated in trials for	Degarelixother 13 trials (9 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Eribulinsmall molecule 13 trials (5 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	FOLFOX Regimen 13 trials (5 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Pazopanibsmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Gefitinibsmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Ramucirumabmonoclonal antibody 12 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Temsirolimussmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Trametinibsmall molecule 12 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Veliparibsmall molecule 12 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Bortezomibsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Copanlisibsmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Dasatinibsmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Thalidomidesmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Akt Inhibitor MK2206 10 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Anastrozolesmall molecule 10 trials (6 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Sirolimussmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Abirateronesmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Adebrelimabmonoclonal antibody 9 trials (6 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Cobimetinibsmall molecule 9 trials (5 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Dexamethasonesmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Filgrastimother 9 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Flutamidesmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Hydroxychloroquinesmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Niraparibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Pegargiminaseother 9 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Ruxolitinibsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Selumetinibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Vorinostatsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Avelumabmonoclonal antibody 8 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Belzutifansmall molecule 8 trials (7 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Binimetinibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Cemiplimabmonoclonal antibody 8 trials (7 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Cixutumumabmonoclonal antibody 8 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Exemestanesmall molecule 8 trials (5 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Hormone Therapy 8 trials (7 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Topotecansmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Vinorelbinesmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	FOLFOX-4 Regimen 7 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Panitumumabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Pegfilgrastimother 7 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Relugolixsmall molecule 7 trials (7 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Talazoparibsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Afatinibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Aspirinsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabazitaxelsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Capivasertibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Ganetespibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenalidomidesmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Mitomycinsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Ribociclibsmall molecule 6 trials (5 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Serplulimabmonoclonal antibody 6 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Tegafursmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Tivozanibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Triptorelinother 6 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Zoledronic Acidsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Adavosertibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Alisertibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Celecoxibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Dabrafenibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Lutetium (177lu) Vipivotide Tetraxetanother 5 trials (5 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Megestrolsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Nintedanibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Osimertinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Rucaparibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Temozolomidesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Vemurafenibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Vismodegibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Alvocidibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Anti-PD1 Monoclonal Antibody 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Belinostatsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	CAPOX Regimen 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Crizotinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Encorafenibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Fruquintinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Ganitumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Histrelinother 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Icotinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Immune Checkpoint Inhibitor 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Luminespibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Pasireotideother 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Romidepsinother 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Selpercatinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Talimogene Laherparepvecgene therapy 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Zanidatamabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Afliberceptother 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Arsenic Trioxidesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Capmatinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Ceritinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Daratumumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Darolutamidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Decitabinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Dostarlimabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Dovitinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Enfortumab Vedotinadc 3 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Entrectinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Estramustinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Firmonertinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	FOLFIRI Regimen 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Guadecitabinesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Idarubicinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Imatinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Immunotherapy 3 trials (3 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipilimumab/Nivolumab Regimen 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Linifanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Margetuximabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Melphalansmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Mitoxantronesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Nilutamidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Pralsetinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Sacituzumab Govitecanadc 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Sapanisertibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Savolitinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Selinexorsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Sonidegibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Tanespimycinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Tazemetostatsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Tipifarnibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Vandetanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Vincristinesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Adjuvant Chemotherapy 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Alpelisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Aromatase Inhibitor 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Avutometinib And Defactinib 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Buserelinother 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyproterone Acetatesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Denosumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Dordavipronesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Elacestrantsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Elimusertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Erdafitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Imiquimodsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Imlunestrantsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Immunomodulatory Oligonucleotide 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipatasertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Linsitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Lorlatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Glandular Cell Neoplasm	2	Observed	clinicaltrials	graph →

Glandular Cell Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 295show all (up to 200)

→ investigated in trials for

Bevacizumabmonoclonal antibody

220 trials (93 active) · roll-up of the cancer and its descendants

—

220

Observed

→ investigated in trials for

Sorafenibsmall molecule

183 trials (13 active) · roll-up of the cancer and its descendants

—

183

Observed

→ investigated in trials for

Gemcitabinesmall molecule

167 trials (45 active) · roll-up of the cancer and its descendants

—

167

Observed

→ investigated in trials for

Pembrolizumabmonoclonal antibody

154 trials (65 active) · roll-up of the cancer and its descendants

—

154

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

148 trials (65 active) · roll-up of the cancer and its descendants

—

148

Observed

→ investigated in trials for

Lenvatinibsmall molecule

145 trials (63 active) · roll-up of the cancer and its descendants

—

145

Observed

→ investigated in trials for

Paclitaxelsmall molecule

139 trials (51 active) · roll-up of the cancer and its descendants

—

139

Observed

→ investigated in trials for

Trastuzumabmonoclonal antibody

130 trials (41 active) · roll-up of the cancer and its descendants

—

130

Observed

→ investigated in trials for

Fluorouracilsmall molecule

127 trials (30 active) · roll-up of the cancer and its descendants

—

127

Observed

→ investigated in trials for

Oxaliplatinsmall molecule

117 trials (30 active) · roll-up of the cancer and its descendants

—

117

Observed

→ investigated in trials for

Carboplatinsmall molecule

104 trials (44 active) · roll-up of the cancer and its descendants

—

104

Observed

→ investigated in trials for

Capecitabinesmall molecule

96 trials (32 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nab-paclitaxel

90 trials (31 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Atezolizumabmonoclonal antibody

86 trials (57 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cyclophosphamidesmall molecule

84 trials (31 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Leucovorinsmall molecule

84 trials (22 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Durvalumabmonoclonal antibody

82 trials (50 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Docetaxelsmall molecule

76 trials (27 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabozantinibsmall molecule

70 trials (38 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cisplatinsmall molecule

67 trials (19 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipilimumabmonoclonal antibody

65 trials (38 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Irinotecansmall molecule

65 trials (19 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Doxorubicinsmall molecule

60 trials (20 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pertuzumabmonoclonal antibody

58 trials (28 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sintilimabmonoclonal antibody

58 trials (28 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tremelimumabmonoclonal antibody

42 trials (27 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tislelizumabmonoclonal antibody

40 trials (18 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Prednisonesmall molecule

36 trials (14 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Regorafenibsmall molecule

36 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Camrelizumabmonoclonal antibody

35 trials (15 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Olaparibsmall molecule

35 trials (21 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sunitinibsmall molecule

33 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Toripalimabmonoclonal antibody

32 trials (12 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fludarabinesmall molecule

31 trials (14 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Leuprolideother

31 trials (14 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Axitinibsmall molecule

30 trials (13 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enzalutamidesmall molecule

30 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumab Emtansineadc

30 trials (13 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Goserelinother

29 trials (15 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Everolimussmall molecule

27 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Letrozolesmall molecule

27 trials (15 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenib Tosylatesmall molecule

27 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cetuximabmonoclonal antibody

26 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinib Hydrochloridesmall molecule

26 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pyrotinibsmall molecule

24 trials (15 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bicalutamidesmall molecule

23 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Chemotherapy

23 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinibsmall molecule

23 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abiraterone Acetatesmall molecule

21 trials (11 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Metforminsmall molecule

21 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pemetrexedsmall molecule

21 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tucatinibsmall molecule

21 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Epirubicinsmall molecule

20 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abemaciclibsmall molecule

19 trials (11 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Palbociclibsmall molecule

19 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fulvestrantsmall molecule

18 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Apalutamidesmall molecule

17 trials (11 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tamoxifensmall molecule

17 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Neratinibsmall molecule

16 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aldesleukinother

15 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cediranibsmall molecule

15 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lapatinibsmall molecule

15 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Degarelixother

13 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Eribulinsmall molecule

13 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

FOLFOX Regimen

13 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pazopanibsmall molecule

13 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Gefitinibsmall molecule

12 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ramucirumabmonoclonal antibody

12 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temsirolimussmall molecule

12 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trametinibsmall molecule

12 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Veliparibsmall molecule

12 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bortezomibsmall molecule

11 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Copanlisibsmall molecule

11 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dasatinibsmall molecule

11 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Thalidomidesmall molecule

11 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Akt Inhibitor MK2206

10 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Anastrozolesmall molecule

10 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sirolimussmall molecule

10 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abirateronesmall molecule

9 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adebrelimabmonoclonal antibody

9 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cobimetinibsmall molecule

9 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dexamethasonesmall molecule

9 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Etoposidesmall molecule

9 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Filgrastimother

9 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Flutamidesmall molecule

9 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Hydroxychloroquinesmall molecule

9 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Niraparibsmall molecule

9 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pegargiminaseother

9 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ruxolitinibsmall molecule

9 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selumetinibsmall molecule

9 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vorinostatsmall molecule

9 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Avelumabmonoclonal antibody

8 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Belzutifansmall molecule

8 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Binimetinibsmall molecule

8 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cemiplimabmonoclonal antibody

8 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cixutumumabmonoclonal antibody

8 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Exemestanesmall molecule

8 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Hormone Therapy

8 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Topotecansmall molecule

8 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vinorelbinesmall molecule

8 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

FOLFOX-4 Regimen

7 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Panitumumabmonoclonal antibody

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pegfilgrastimother

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Relugolixsmall molecule

7 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Talazoparibsmall molecule

7 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Afatinibsmall molecule

6 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aspirinsmall molecule

6 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabazitaxelsmall molecule

6 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capivasertibsmall molecule

6 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ganetespibsmall molecule

6 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenalidomidesmall molecule

6 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mitomycinsmall molecule

6 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ribociclibsmall molecule

6 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Serplulimabmonoclonal antibody

6 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tegafursmall molecule

6 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tivozanibsmall molecule

6 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Triptorelinother

6 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zoledronic Acidsmall molecule

6 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adavosertibsmall molecule

5 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alisertibsmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Celecoxibsmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dabrafenibsmall molecule

5 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lutetium (177lu) Vipivotide Tetraxetanother

5 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Megestrolsmall molecule

5 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nintedanibsmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Osimertinibsmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rucaparibsmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temozolomidesmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vemurafenibsmall molecule

5 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vismodegibsmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alvocidibsmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Anti-PD1 Monoclonal Antibody

→ investigated in trials for

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Belinostatsmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

CAPOX Regimen

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Crizotinibsmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Encorafenibsmall molecule

4 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fruquintinibsmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ganitumabmonoclonal antibody

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Histrelinother

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Icotinibsmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Immune Checkpoint Inhibitor

→ investigated in trials for

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Luminespibsmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pasireotideother

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Romidepsinother

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selpercatinibsmall molecule

4 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Talimogene Laherparepvecgene therapy

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zanidatamabmonoclonal antibody

4 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Afliberceptother

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Arsenic Trioxidesmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capmatinibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ceritinibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Daratumumabmonoclonal antibody

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Darolutamidesmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Decitabinesmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dostarlimabmonoclonal antibody

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dovitinibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enfortumab Vedotinadc

3 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Entrectinibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Estramustinesmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Firmonertinibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

FOLFIRI Regimen

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Guadecitabinesmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Idarubicinsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Imatinibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Immunotherapy

3 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

Ipilimumab/Nivolumab Regimen

→ investigated in trials for

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Linifanibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Margetuximabmonoclonal antibody

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Melphalansmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mitoxantronesmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nilutamidesmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pralsetinibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sacituzumab Govitecanadc

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sapanisertibsmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Savolitinibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selinexorsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sonidegibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tanespimycinsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tazemetostatsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tipifarnibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vandetanibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vincristinesmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adjuvant Chemotherapy

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alpelisibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aromatase Inhibitor

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor

→ investigated in trials for

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Avutometinib And Defactinib

→ investigated in trials for

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Buserelinother

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cyproterone Acetatesmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Denosumabmonoclonal antibody

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dordavipronesmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Elacestrantsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Elimusertibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erdafitinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Imiquimodsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Imlunestrantsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

Immunomodulatory Oligonucleotide

→ investigated in trials for

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipatasertibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Linsitinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lorlatinibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Glandular Cell Neoplasm studied in …STUDIED_INderived10 of 6,437show all (up to 200)
→ studied in	NCT00423306Phase 2 · completed A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 6,437 trials mapped (2,172 active)	—	—	Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02345265Phase 2 · active not recruiting Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 6,437 trials mapped (2,172 active)	—	—	Fallopian Tube Endometrioid Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02446600Phase 3 · active not recruiting Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 6,437 trials mapped (2,172 active)	—	—	Fallopian Tube Clear Cell Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02502266Phase 2/Phase 3 · active not recruiting Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 6,437 trials mapped (2,172 active)	—	—	Fallopian Tube Clear Cell Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03348631Phase 2 · active not recruiting Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 6,437 trials mapped (2,172 active)	—	—	Ovarian Endometrioid Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03598257Phase 2 · active not recruiting Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer · condition mapped ONTOLOGY_EXACT · 6,437 trials mapped (2,172 active)	—	—	Breast Inflammatory Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 6,437 trials mapped (2,172 active)	—	—	Collecting Duct Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03897543Phase 1/Phase 2 · completed ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma · condition mapped ALIAS · 6,437 trials mapped (2,172 active)	—	—	Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04175912Phase 2 · active not recruiting Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver · condition mapped CURATED_BROADER · 6,437 trials mapped (2,172 active)	—	—	Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04548752Phase 2 · active not recruiting Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations · condition mapped CURATED_BROADER · 6,437 trials mapped (2,172 active)	—	—	Pancreatic Adenocarcinoma	1	Observed	clinicaltrials	graph →

Glandular Cell Neoplasm studied in …STUDIED_INderived10 of 6,437show all (up to 200)

→ studied in

NCT00423306Phase 2 · completed

A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 6,437 trials mapped (2,172 active)

—

Hepatocellular Carcinoma

Observed

Fallopian Tube Endometrioid Adenocarcinoma

→ studied in

NCT02345265Phase 2 · active not recruiting

Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 6,437 trials mapped (2,172 active)

—

Observed

Fallopian Tube Clear Cell Adenocarcinoma

→ studied in

NCT02446600Phase 3 · active not recruiting

Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 6,437 trials mapped (2,172 active)

—

Observed

Fallopian Tube Clear Cell Adenocarcinoma

→ studied in

NCT02502266Phase 2/Phase 3 · active not recruiting

Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 6,437 trials mapped (2,172 active)

—

Observed

Ovarian Endometrioid Adenocarcinoma

→ studied in

NCT03348631Phase 2 · active not recruiting

Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 6,437 trials mapped (2,172 active)

—

Observed

Breast Inflammatory Carcinoma

→ studied in

NCT03598257Phase 2 · active not recruiting

Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer · condition mapped ONTOLOGY_EXACT · 6,437 trials mapped (2,172 active)

—

Observed

Collecting Duct Carcinoma

→ studied in

NCT03866382Phase 2 · recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 6,437 trials mapped (2,172 active)

—

Observed

→ studied in

NCT03897543Phase 1/Phase 2 · completed

ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma · condition mapped ALIAS · 6,437 trials mapped (2,172 active)

—

Hepatocellular Carcinoma

Observed

→ studied in

NCT04175912Phase 2 · active not recruiting

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver · condition mapped CURATED_BROADER · 6,437 trials mapped (2,172 active)

—

Hepatocellular Carcinoma

Observed

Pancreatic Adenocarcinoma

→ studied in

NCT04548752Phase 2 · active not recruiting

Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations · condition mapped CURATED_BROADER · 6,437 trials mapped (2,172 active)

—

Observed